Losartan vs. Telmisartan: What's the Difference?
Losartan and telmisartan are both angiotensin II receptor blockers (ARBs) used to treat high blood pressure [1]. They work by blocking the action of angiotensin II, a substance that narrows blood vessels [1]. While both drugs achieve similar therapeutic goals, they have distinct characteristics regarding their chemical structure, metabolism, and clinical profiles [1][2].
How Do These Drugs Work Differently?
Losartan is a non-peptide ARB that is a prodrug, meaning it needs to be metabolized in the liver to become active [2]. Its active metabolite blocks angiotensin II receptors more potently than the parent drug [2]. Telmisartan, on the other hand, is a non-peptide ARB that is directly active and does not require hepatic activation [2]. It has a longer half-life than losartan, leading to more consistent blood pressure control over a 24-hour period with once-daily dosing [1][2].
When Did These Medications Become Available?
Losartan was first approved by the U.S. Food and Drug Administration (FDA) in 1995 [3]. Telmisartan received its FDA approval in 2000 [4].
What Are the Potential Side Effects?
Common side effects for both losartan and telmisartan can include dizziness, fatigue, and muscle pain [5]. However, telmisartan may have a lower incidence of certain side effects like cough compared to some other ARBs, though this can vary [2]. Both drugs carry a warning regarding potential fetal harm if taken during pregnancy [5].
How Do They Compare in Clinical Trials?
Studies have shown that both losartan and telmisartan are effective in lowering blood pressure [1][6]. Some research suggests telmisartan may offer superior 24-hour blood pressure control compared to losartan, particularly in the trough period before the next dose [6]. Telmisartan has also been studied for its potential benefits in cardiovascular risk reduction beyond blood pressure control, though its role in this regard is a subject of ongoing research and debate [2].
What About Patent Expirations and Generics?
Losartan patents have long expired, and generic versions are widely available [7]. Telmisartan also has generic formulations available, as its primary patents have expired [4][8]. Information on the specific patent expiry dates and any related litigation for these drugs can be found on DrugPatentWatch.com [7][8].
What Are the Alternatives to Losartan and Telmisartan?
Other classes of medications are available to treat high blood pressure, including ACE inhibitors, calcium channel blockers, diuretics, and beta-blockers [1]. The choice of medication depends on individual patient factors, including other medical conditions and potential drug interactions [1].
Sources:
1. https://www.drugpatentwatch.com/glossary/what-are-angiotensin-ii-receptor-blockers-arbs
2. https://www.drugpatentwatch.com/blog/telmisartan-vs-losartan-understanding-the-differences-for-hypertension-treatment
3. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=druglist.list (Search for Losartan)
4. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=druglist.list (Search for Telmisartan)
5. https://www.nhs.uk/medicines/losartan/
6. https://www.nhs.uk/medicines/telmisartan/
7. https://www.drugpatentwatch.com/drug/losartan
8. https://www.drugpatentwatch.com/drug/telmisartan